Clinical Trial Update: Study of Blood Samples From High-Risk Postmenopausal Women Who Received Treatment on Breast Cancer Prevention Clinical Trials NSABP-P-1 or NSABP-P-2

View source ↗

Summary

This update describes a study collecting blood samples from high-risk postmenopausal women who participated in the breast cancer prevention trials NSABP-P-1 and…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Evista (raloxifene)
• Nolvadex (tamoxifen)

Snippet

Sponsor: NSABP Foundation Inc | Conditions: Breast Cancer | Status: UNKNOWN